Trachyonychia can occur in patients of all ages, though children tend to be more frequently affected. The condition can evolve idiopathically as well as in association with a wide variety of dermatologic and nondermatologic diseases. Trachyonychia was described as early as 1950 by Alkiewicz [1] . Hazelrigg et al. [2] termed the acquired, idiopathic version of this clinical entity as twenty nail dystrophy (TND) in 1977 because it was initially described as uniformly affecting all twenty nails and toenails. However, later reports describe cases of characteristic nail changes occurring in some nails and not others or in different degrees of severity in all twenty nails.
There have been arguments to abandon the term TND because it carries no specific significance or information on the underlying cause of the disorder [3] . We agree and avoid the use of the term TND because there are multiple conditions which can result in dystrophy of all twenty nails, aside from trachyonychia. The term TND lacks specificity. The scientific literature includes commentaries dividing trachyonychia into two subtypes, opaque and shiny trachyonychia, arguing that this division may provide more information on the severity of the condition [3, 4] .
While trachyonychia has a characteristic appearance, there are overlap clinical features with other nail unit dermatoses, so an open mind for a complete differential diagnosis should be maintained. In particular, onychomy-
Introduction
Trachyonychia is a disorder of the nail unit that most commonly presents with rough, longitudinally ridged nails (opaque trachyonychia) or less frequently, uniform, opalescent nails with pits (shiny trachyonychia). The term trachyonychia refers to 'rough nails.' The appearance has also been likened to the nails being rubbed with sandpaper, and has therefore also been referred to colloquially as 'sandpapered nails.' It can involve from one nail up to all twenty nails, and multiple nails are usually affected at the time of presentation to a physician. cosis may appear very similar to trachyonychia, so early appropriate evaluation for that disorder is needed. In this review, we will describe the clinical characteristics of trachyonychia, the evaluation and workup of the condition, hallmark histopathological characteristics, and potential therapeutic options.
Clinical Characteristics
Rough nails with excessive longitudinal ridging are typically seen in patients with trachyonychia. The nail plates may be thickened or thinned. Cuticles are usually thickened and ragged [5] . The two different subtypes of trachyonychia were first described by Baran [6] in 1981 and are categorized by their clinical appearance and severity ( table 1 ) . Opaque trachyonychia, the more severe type, is characterized by rough nails that appear to have been rubbed by sandpaper ( fig. 1 ). The less severe type, shiny trachyonychia, is characterized by shiny, opalescent nails with numerous pits ( fig. 2 ). Although both opaque trachyonychia and shiny trachyonychia can both be seen in association with alopecia areata, shiny trachyonychia is most often linked to alopecia areata. The histolopathologic differences between these two subtypes have been well described by Tosti et al. [7] . Nail changes in the case of opaque trachyonychia are produced by a remittent, waxing and waning inflammatory insult to the nail matrix that never ceases [7] . However, in the case of shiny trachyonychia, there is an intermittent, focal, and regularly recurrent inflammatory insult to the matrix that is separated by periods of normal matrix function [7] . These differences in the distribution and timing of inflammation within the nail unit result in the two distinct clinical types of trachyonychia. It has been reported that of the two types, opaque trachyonychia is more commonly seen [5] and can be characterized by a more severe clinical course [8] .
Trachyonychia was initially thought to occur exclusively in children, but subsequently cases in adults had also been recognized. It remains more common in the pediatric population with the peak age of onset between the age of 3 and 12 years [9, 10] . The incidence of trachyonychia in both adults and children is not known. One study found childhood onset trachyonychia to have a male predominance compared to adult onset trachyonychia which has been reported to have a female predominance [11] , but these findings have not been confirmed in other patient populations. In those patients with both trachyonychia and alopecia areata, there is a variable temporal relationship between nail changes and disease progression. One study found roughly similar numbers of patients experiencing nail changes before, after, and simultaneous to hair loss [12] . There have been many reports of idiopathic trachyonychia, which is characterized by the development of isolated nail involvement in the absence of a personal history or signs of cutaneous disease [9] . In these patients, opaque trachyonychia is the more common clinical subtype. Multiple reports of a hereditary form of trachyonychia exist in the literature occurring in monozygotic twins [13, 14] and within three generations of one family [15] , suggesting that there may be some underlying genetic predisposition. All familial cases were described as occurring in the absence of any skin changes or abnormalities.
In our experience, a majority of cases of trachyonychia referred to the nail clinic are idiopathic. However, trachyonychia has been associated with a number of dermatologic and nondermatologic diseases, and the most frequent associations are with alopecia areata/universalis, psoriasis, and lichen planus ( table 2 a, b). Some chemotherapeutic agents and kinase inhibitors have also been reported to cause trachyonychia [16, 17] .
Koilonychia has been reported to occur concurrently with other hallmark manifestations of trachyonychia, and in the absence of other known associated conditions [8, 9, [18] [19] [20] [21] . In our experience, koilonychia is commonly found clinically with the opaque subtype of trachyonychia.
Evaluation
When evaluating a patient with trachyonychia, it is important to consider other causes of nail dystrophy in the differential diagnosis. We employ a four-step process in evaluating patients who present with clinical findings of trachyonychia ( fig. 3 ). First, a personal and family history of skin disorders is obtained, as well as a careful examination of the skin, mucosa, and hair to evaluate for associated disorders [5] . Because of overlap features of trachyonychia with onychomycosis, it is helpful for a patient with newly diagnosed trachyonychia to be evaluated for onychomycosis. To accomplish this, we utilize nail clippings for histopathologic examination, including Periodic Acid-Schiff (PAS) staining. This procedure is noninvasive, bears little to no risk to the patient, and may also provide other clues to the underlying diagnosis. For example, histologic features of nail unit psoriasis may be present [22] in a nail clipping from a patient with idiopathic trachyonychia.
In general, nail unit biopsies are disfavored in the evaluation of trachyonychia or to further establish a specific underlying diagnosis. However, nail unit biopsy has a role in trachyonychia for severe cases, recalcitrant cases, or when the clinical diagnosis is ambiguous [23] . Longitudinal nail unit biopsy has the advantage of evaluation of multiple anatomic areas of the nail unit. If a nail unit biopsy reveals a primary cause for trachyonychia, such as psoriasis or lichen planus, systemic therapies may be implemented. One study found longitudinal biopsy helpful in making a diagnosis in 52.3% of TND cases [23] . However, 65.6% of patients in this study had concomitant cutaneous findings of different dermatoses [23] . Since these patients had nail findings associated with other dermatologic conditions, it is difficult to extrapolate this evidence to cases of true idiopathic trachyonychia. Because there is a potential for postprocedure nail dystrophy, secondary infection, and reduction of total nail width [23] , careful risk/benefit analysis must be implemented before performing the procedure. Other types of nail unit biopsies could be considered but have the disadvantage of examining less area of a particular nail unit, and the distribution Ichthyosis vulgaris [33] Vitiligo [34, 35] Atopic dermatitis [36] Pemphigus vulgaris [29] Incontinentia pigmenti [37] Congenital cutaneous candidiasis [38] Hereditary punctate palmoplantar keratoderma [39] Darier's disease [40] Judo nails [41] Knuckle pads [42] Hay-Wells syndrome [43] b
Immunoglobulin A deficiency [44] Balanced translocation 46, XX, t(6q13;10p13) [45] Immune thrombocytopenic purpura [46] Autoimmune hemolytic anemia [46] Amyloidosis [47] Sarcoidosis [48] Reflex sympathetic dystrophy [49] Down syndrome [50] Haber/Chairatchaneeboon/Rubin of the inflammation present may be variable, making a definitive diagnosis more difficult.
Histopathology
While biopsy is not routinely performed in the evaluation of trachyonychia, there have been several studies that have evaluated the histopathologic features of it. Wilkinson et al. [24] were the first authors to identify a distinctive histology in cases of idiopathic trachyonychia of focal spongiotic inflammation of the nail matrix. Based on this, other authors have proposed that idiopathic trachyonychia may be a subgroup of endogenous eczema affecting only the nail matrix or alternatively an autoimmune response against the nail matrix [25] .
Many studies and case reports describe histologic findings of patients with trachyonychia ( table 3 a, b). Tosti et al. [9, 12] have looked in detail at the histopathology of the nail unit in patients with both idiopathic trachyonychia and trachyonychia associated with alopecia areata. They found that in both variants of trachyonychia, the majority of patients exhibit spongiotic changes in the nail apparatus and nail unit epithelia associated with mild-tomoderate lymphocytic infiltration and exocytosis [9, 12] . Of 43 patients with reported idiopathic trachyonychia and nail unit biopsy specimens, 7 were reported to have findings of lichen planus [9, 26, 27 ] , 4 to have psoriasiform changes [9, 28] , and 1 to have histological characteristics of pemphigus vulgaris [29] ( table 4 a). The 1 patient with pemphigus vulgaris on nail unit biopsy [29] went on to develop mucocutaneous lesions.
Of 16 patients with trachyonychia associated with alopecia areata, 14 were reported to exhibit spongiotic changes on nail biopsy ( table 4 b). The remaining 2 patients were reported to have histological changes characteristic of lichen planus [12, 30] . One of these patients went on to develop cutaneous lichen planus 6 months after the biopsy and therefore likely did not have nail changes secondary to alopecia areata, but rather lichen planus involving the nail unit [12] .
Treatment
In many patients, nail changes of trachyonychia are self-limited. Children have a shorter duration of disease than adults, with one study reporting a median disease duration of 32.5 ± 9.7 months in children versus 77.0 ± 10 months in adults (p = 0.002) [11] . The same group also found a longer disease duration in female patients (82.5 ± 12.7 months) than male patients (63.7 ± 14.8 months) (p = 0.007) [11] . Upon follow-up of 12 patients with trachyonychia, 50% had spontaneous resolution within the first 6 years, with an average disease duration of 42 months [4] . Another study found that 82% of pediatric patients had an improvement in their nails after an average of 66 months of follow-up regardless of treatment type and duration [10] . While there is no definitive data on the amount of time it takes trachyonychia to improve, there is a good deal of evidence that nail findings improve on 113 their own over time. Because trachyonychia is a nonscarring condition, observation of the nails affords minimal long-term risk to the patient. As a result, counseling, reassurance, active nonintervention, and the tincture of time are reasonable treatment options for this disease. While trachyonychia is not harmful to the patient, nail diseases have been shown to have a negative effect on the patients' quality of life. For those who request treatment, various treatment options have been well documented in patients with trachyonychia ( table 3 a, b) . In this table, we have included treatments attempted on only 1 or 2 patients, since there are very few large-scale controlled studies in patients with this disease. There is no single evidence-based therapy that is reliably effective, and it can be difficult to choose a specific therapy due to limited data. In addition, there is no objective measure for assessing improvement in these patients so it is difficult to quantify degree of clinical improvement in a way that is meaningful in comparing one treatment to another. In patients who have trachyonychia associated with an underlying disease, treatments for the associated disease may be beneficial in improving the appearance of the nails ( table 3 c). In patients with shiny trachyonychia, nail cosmetics are a low-risk treatment option that may help alleviate the visibility of nail changes. Male patients with shiny trachyonychia may consider a clear polish to improve the appearance of the nails. Despite the benign and often self-limited nature of the disease, some patients will desire therapy. Our treatment algorithm begins with observation/active nonintervention followed by a trial period of topical treatments ( fig. 4 ) . In our experience, most patients are referred to the nail specialty clinic after failing topical medications. In this case, if the patient requests further treatment, nail unit steroid injections may be considered. In our experience, for pediatric patients in particular, pretreatment with an anesthetic cream and use of a vibratory device can help with the discomfort of nail unit injections.
In adults, we have a lower threshold for active treatment and intervention, since the appearance of the nails can be bothersome and can affect quality of life. In particular, adults who have professions with frequent interaction with the public, and where the hands are often visible, such as salespeople, often are concerned about the nail changes of trachyonychia affecting their professional success. Since trachyonychia is a benign condition and children tend to have shorter disease courses, pediatric patients warrant a more conservative approach. If children are bothered by their nails or parents push for treatment, the same algorithm can be applied ( fig. 4 ).
Summary
The exact etiology of the inflammation that affects the nail unit in patients with trachyonychia continues to remain unclear. Tosti et al. [7] have suggested that based on the clinical and pathologic appearance of the nails, idiopathic trachyonychia may represent a subset of alopecia areata that is limited to the nails. Because trachyonychia is associated with a number of dermatologic diseases ( table 2 a), patients who present clinically with trachyonychia should undergo a comprehensive skin exam. Additionally, these patients need future follow-up as nail changes associated with idiopathic trachyonychia can sometimes precede the development of other cutaneous diseases. It is important to counsel patients on the benign nature of the disease and the generally good prognosis. Even with counseling, some patients may experience distress over their nail changes and request treatment. The age of the patient, the subtype of trachyonychia, the severity of trachyonychia, prior treatments attempted, and associated dermatologic and nondermatologic diseases should all be taken into account when determining the best treatment regimen for the patient.
